For the latest
cancer COVID-19 resources, click on this link
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
Nottingham University, UK
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published: 3 Dec 2008
Prof. Poulam Patel
Extended, escalated dose chemo shows no survival benefit in advanced melanoma.
Melanoma & skin
Updates in geriatric medical oncology from SIOG meeting
Dr Enrique Soto - Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zu...
28 Oct 2020
Treating ALL patients during the COVID-19 pandemic
Prof David Marks - University hospital Bristol NHS Foundation Trust, Bristol, UK
15 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
22 Sep 2020
COMBI-AD trial: Adjuvant dabrafenib plus trametinib in patients with resected st...
Prof Axel Hauschild - University Hospital, Schleswig-Holstein, Germany
30 Jun 2020
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients wit...
Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
1 May 2020
Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated m...
Prof Alain Algazi -University of California San Francisco, San Francisco, USA
30 Apr 2020